Search Results - "Parsons, Nathan B"

Burden of Diabetic Foot Ulcers for Medicare and Private Insurers by RICE, J. Bradford, DESAI, Urvi, CUMMINGS, Alice Kate G, BIRNBAUM, Howard G, SKORNICKI, Michelle, PARSONS, Nathan B

“…To estimate the annual, per-patient incremental burden of diabetic foot ulcers (DFUs). DFU patients and non-DFU patients with diabetes (controls) were selected…”
Get full text

Comparative effectiveness of a bilayered living cellular construct and a porcine collagen wound dressing in the treatment of venous leg ulcers by Marston, William A., Sabolinski, Michael L., Parsons, Nathan B., Kirsner, Robert S.

“…Using data from a national wound‐specific electronic medical record (WoundExpert, Net Health, Pittsburgh, PA), we compared the effectiveness of a bilayered…”
Get full text

Comparative effectiveness of a bioengineered living cellular construct vs. a dehydrated human amniotic membrane allograft for the treatment of diabetic foot ulcers in a real world setting by Kirsner, Robert S., Sabolinski, Michael L., Parsons, Nathan B., Skornicki, Michelle, Marston, William A.

“…ABSTRACT We evaluated the comparative effectiveness of a bioengineered living cellular construct (BLCC) and a dehydrated human amnion/chorion membrane…”
Get full text

The Comparative Effectiveness of a Human Fibroblast Dermal Substitute versus a Dehydrated Human Amnion/Chorion Membrane Allograft for the Treatment of Diabetic Foot Ulcers in a Real-world Setting by Kraus, Ira, Sabolinski, Michael L, Skornicki, Michelle, Parsons, Nathan B

“…Impaired wound healing is associated with serious complications in patients with diabetes. Diabetic foot ulcers (DFUs) can lead to costly complications and an…”
Get full text

Evaluation of Wound Closure Rates Using a Human Fibroblast-derived Dermal Substitute Versus a Fetal Bovine Collagen Dressing: A Retrospective Study by Fitzgerald, Ryan H, Sabolinski, Michael L, Skornicki, Michelle, Parsons, Nathan B

“…Diabetic foot ulcers (DFUs) are associated with an increased risk for serious and costly outcomes such as osteomyelitis, amputation, and hospitalization…”
Get full text

Economic outcomes among Medicare patients receiving bioengineered cellular technologies for treatment of diabetic foot ulcers by Rice, J Bradford, Desai, Urvi, Ristovska, Ljubica, Cummings, Alice Kate G, Birnbaum, Howard G, Skornicki, Michelle, Margolis, David J, Parsons, Nathan B

“…To assess the real-world medical services utilization and associated costs of Medicare patients with diabetic foot ulcers (DFUs) treated with Apligraf…”
Get more information

Burden of Diabetic Foot Ulcers for Medicare and Private Insurers. Diabetes Care 2014;37:651–658 by Rice, J. Bradford, Desai, Urvi, Cummings, Alice Kate G., Birnbaum, Howard G., Skornicki, Michelle, Parsons, Nathan B.

Get full text